Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FZS88
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,049
Award facts
- Contract value 100% obligated
- $31,048.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $31,048.80 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 Unit Vials. The contract was executed on September 24, 2025, with an ultimate completion date of October 16, 2025, and will be performed in Park Ridge, Illinois. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small business.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026, which authorizes the agency to procure a broad range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group, established in 2001 and based in Park Ridge, Illinois, serves as a critical supplier in the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to military health systems. The company has demonstrated consistent success in securing DLA delivery orders across diverse therapeutic categories, positioning it as a preferred vendor for specialized pharmaceutical products including injectable medications and high-value pharmaceutical therapies.
Quick answers
Who was awarded contract SPE2DB25FZS88?
SPE2DB25FZS88 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FZS88 worth?
The government has obligated $31,049 on SPE2DB25FZS88.
Is contract SPE2DB25FZS88 an order under another contract?
Yes. SPE2DB25FZS88 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB25FZS88 competed?
The extent of competition for SPE2DB25FZS88 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award